Matthew R. Murray, MD
Pediatrician
New York, NY 10021
Tel: 212.774.7182
Fax: 212.606.1614
About Dr. Murray
Insurance
BCBS Anthem Gatekeeper Individual Network
BCBS Federal
BCBS Anthem of NY (formerly Empire)
BCBS Horizon (excluding OMNIA)
Cigna
Connecticare (not through Access Health CT)
EmblemHealth GHI
EmblemHealth HIP
EmblemHealth Medicare
EmblemHealth Select Care
The Empire Plan / NYSHIP
Medicare Part B
Oxford
UnitedHealthcare
UnitedHealthcare Compass
UnitedHealthcare Medicare HMO
UnitedHealthcare Medicare PPO
If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Credentials
Appointments
Attending Pediatrician, Hospital for Special Surgery
Assistant Professor of Pediatrics, Weill Cornell Medical College
Assistant Professor of Pediatrics, NewYork-Presbyterian Hospital
Certifications
American Board of Pediatrics
Education
Johns Hopkins School of Medicine, 2019
Residency: Weill Cornell Pediatrics, 2022
State Licensure
New York
Languages
EnglishFor My Patients
Publications by Dr. Murray
Research
Clinical Trials / Research Studies
Industry Relationships
HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.
As of May 11, 2023, Dr. Murray reported no relationships with the healthcare industry.
HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.